Alnylam Pharmaceuticals
ALNY
#649
Rank
C$55.18 B
Marketcap
C$413.34
Share price
-0.61%
Change (1 day)
-7.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company